Molecular imaging of HER2 expression using a multifunctional Affibody molecule

被引：0
|
作者：
Tran, T. A.
Rosik, D. [1 ]
Abrahmsen, L. [1 ]
Sandstrom, M. [2 ]
Sjoberg, A. [1 ]
Wallberg, H. [3 ]
Ahlgren, S. [4 ]
Orlova, A.
Tolmachev, V.
机构：
[1] Affibody AB, Bromma, Sweden
[2] Univ Uppsala Hosp, Dept Oncol, Hosp Phys, S-75185 Uppsala, Sweden
[3] Royal Inst Technol, Sch Biotechnol, Div Mol Biotechnol, Stockholm, Sweden
[4] Dept Med Sci, Div Nucl Med, Uppsala, Sweden
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S233 / S233
页数：1
相关论文
共 50 条
  • [41] Affibody displaying bionanocapsules for HER2 specific drug delivery
    Nishimura, Yuya
    Shishido, Takuya
    Mieda, Hiroaki
    Tanaka, Tsutomu
    Ogino, Chiaki
    Kondo, Akihiko
    JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2009, 108 : S27 - S27
  • [42] Preliminary evaluation of 89Zr-Labeled Affibody for PET imaging of Tumors Expressing HER2
    Xu, Y.
    Bai, Z.
    Pan, D.
    Wang, L.
    Yan, J.
    Yang, R.
    Yang, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S656 - S656
  • [43] An improved radiolabelled RNA aptamer molecule for HER2 imaging in cancers
    Varmira, Kambiz
    Hosseinimehr, Seyed Jalal
    Noaparast, Zohreh
    Abedi, Seyed Mohammad
    JOURNAL OF DRUG TARGETING, 2014, 22 (02) : 116 - 122
  • [44] 111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors
    Tolmachev, V
    Nilsson, FY
    Widström, C
    Andersson, K
    Rosik, D
    Gedda, L
    Wennborg, A
    Orlova, A
    JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (05) : 846 - 853
  • [45] A novel molecular imaging agent for diagnosis of recurrent HER2 positive breast cancer. First time in human study using an Indium-111- or Gallium-68-labeled Affibody molecule
    Baum, R. P.
    Orlova, A.
    Tolmachev, V.
    Feldwisch, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S91 - S91
  • [46] Imaging EGFR and HER2 with small-molecule imaging agents for PET and SPECT
    Corcoran, Emily B.
    Hanson, Robert N.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [47] Non-invasive assessment of HER2 expression in patients with urothelial carcinoma using [68Ga]Ga-HER2 affibody PET/CT imaging: preliminary clinical findings
    Zou, Sijuan
    Liu, Zheng
    Zhou, Jianyuan
    Song, Shuang
    Wang, Dongdong
    Zhu, Dongling
    Cheng, Siyuan
    Cheng, Zhaoting
    Zhu, Yuankai
    Yu, Tianci
    Pan, Donghui
    Yang, Min
    Zhu, Xiaohua
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
  • [48] Evaluating the effect of the chelator on biodistribution of a HER2 imaging agent: DOTA conjugated anti-HER2 Affibody molecule outperforms NODAGA and NOTA in mice bearing prostate cancer xenografts
    Malmberg, Jennie
    Perols, Anna
    Varasteh, Zohreh
    Altai, Mohamed
    Braun, Alexis
    Sandstrom, Mattias
    Garske, Ulrike
    Tolmachev, Vladimir
    Orlova, Anna
    Karlstrom, Amelie Eriksson
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [49] In vivo molecular imaging of HER2 expression in a rat model of Barrett's esophagus adenocarcinoma
    Realdon, S.
    Dassie, E.
    Fassan, M.
    Dall'Olmo, L.
    Hatem, G.
    Buda, A.
    Arcidiacono, D.
    Diamantis, G.
    Zhang, H.
    Greene, M. I.
    Sturniolo, G. C.
    Rugge, M.
    Alberti, A.
    Battaglia, G.
    DISEASES OF THE ESOPHAGUS, 2015, 28 (04) : 394 - 403
  • [50] Selection and characterization of HER2/neu-binding affibody ligands
    Wikman, M
    Steffen, AC
    Gunneriusson, E
    Tolmachev, V
    Adams, GP
    Carlsson, J
    Ståhl, S
    PROTEIN ENGINEERING DESIGN & SELECTION, 2004, 17 (05): : 455 - 462
12345